Kevin Chung

5PUBLICATIONS
43CO-AUTHORS
Social program evaluationCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Apr 17, 2021
Between-center variation in high-priority listing status under the new heart allocation policy.

Gege Ran, Kevin Chung, Allen S Anderson

Pageof 1